Short answer
Direct-to-consumer genetic tests can be useful for ancestry, traits, carrier information, and some health-risk reports. They can also be easy to overread. A result is not the same thing as a diagnosis, and a negative result does not always mean no genetic risk.
What these tests usually do
| Report type | What it may tell you | Key limit |
|---|---|---|
| Ancestry and relatives | Genetic similarity to reference populations or other users. | Results depend on company databases and can change as databases grow. |
| Traits and wellness | Predictions about non-diagnostic traits or wellness-related associations. | Many traits are influenced by many genes plus environment and behavior. |
| Carrier screening | Whether you carry certain variants linked to inherited conditions. | The test may cover only selected variants, not every possible disease-causing variant. |
| Health-risk reports | Some variants linked with increased risk for certain conditions. | Risk is not certainty, and clinical decisions usually need confirmation. |
| Pharmacogenetic reports | Some gene-drug response information. | FDA has warned about unsupported claims for predicting medication response. |
FDA review does not mean unlimited certainty
FDA says direct-to-consumer tests for moderate- to high-risk medical purposes are generally reviewed to determine the validity of the test claims. That is useful, but it does not mean every possible variant is tested, every report is medically complete, or every result should be acted on without professional guidance.
When to seek clinical confirmation
- A result suggests hereditary cancer risk, heart-risk variants, or another high-impact condition.
- A result could change screening, surgery, medication, pregnancy planning, or treatment decisions.
- Your personal or family history suggests risk even if the direct-to-consumer report is negative.
- You uploaded raw DNA data to a third-party interpretation service.
Privacy questions before buying
DNA data can reveal information about you and biological relatives. FTC enforcement actions show that privacy promises matter and can fail. Before buying, review whether the company stores your sample, shares de-identified or identifiable data, lets you delete data, uses data for research, responds to law-enforcement requests, or changes policies after collection.
GINA limits
The Genetic Information Nondiscrimination Act, or GINA, offers federal protections against certain uses of genetic information in health insurance and employment. HHS guidance notes that GINA does not extend to life insurance, disability insurance, or long-term care insurance.
Questions to ask
- Is the specific health claim FDA-reviewed or otherwise supported by strong evidence?
- Which variants are tested, and which are not?
- Does a positive result need clinical confirmation before action?
- Can I speak with a genetic counselor or genetics professional?
- What happens to my sample and data if the company is sold, shuts down, or changes its policy?